Human Rights Watch says Kenya's government should provide medicines and care often denied to young patients

10 September 2010

Kenyan children in acute and chronic pain suffer needlessly because of government policies that restrict access to inexpensive pain medicines, a lack of investment in palliative care services, and inadequately trained health workers, Human Rights Watch said in a report released yesterday.

The 78-page report, titled Needless Pain: Government Failure to Provide Palliative Care for Children in Kenya, found that most Kenyan children with diseases such as cancer or HIV/AIDS are unable to get palliative care or pain medicines. Kenya's few palliative care services provide counseling and support to families of chronically ill patients, as well as pain treatment, but lack programs for children. In addition, the majority of sick children are cared for at home, but there is little support for low-cost home-based palliative care.

Pain medicines cheap and safer

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical